Diego A. Morita, MD

Co-Director, New Onset Seizure Clinic

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4222

Fax 513-636-1888

Email diego.morita@cchmc.org


Epilepsy; therapeutic drug management; pharmacogenetics


Clinical pharmacology; population pharmacokinetics; antiepileptic drug tolerability

Dr. Morita obtained his medical degree with honors from the University of Buenos Aires School of Medicine in Buenos Aires, Argentina. He finished a three-year residency in pediatrics at Buenos Aires British Hospital in Buenos Aires, Argentina. In 1996, he came to the United States and continued his training in pediatrics at Miami Children's Hospital in Miami, Florida.

Dr. Morita was then a resident in neurology at the University of Cincinnati, and later a fellow in child neurology at Cincinnati Children's. He completed fellowship training in clinical neurophysiology and epilepsy, and epilepsy clinical neuropharmacology, both at Cincinnati Children's.

After his fellowships, Dr. Morita opened a child neurology private practice in Buenos Aires, Argentina, and in 2005 returned and joined the faculty at Cincinnati Children's within the University of Cincinnati College of Medicine.

Dr. Morita's interests currently include the objective assessment of antiepileptic drug side effects, pharmacogenetics of antiepileptic drugs, and individualization of drug therapy.

MD: University of Buenos Aires, Buenos Aires, Argentina, 1992.

Residency: Buenos Aires British Hospital, Buenos Aires, Argentina; Miami Children's Hospital, Miami, FL; University of Cincinnati, Cincinnati, OH.

Fellowship: Child Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Clinical Neurophysiology and Epilepsy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Epilepsy Clinical Neuropharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

View PubMed Publications

Modi AC, Guilfoyle SM, Morita DA, Glauser TA. Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy. Epilepsia. 2011 Feb;52(2):370-6. doi: 10.1111/j.1528-1167.2010.02789.x.

Holland KD, Monahan S, Morita D, Vartzelis G, Glauser TA. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand. 2010 Mar;121(3):149-53.

Modi AC, King AS, Monahan SR, Koumoutsos JE, Morita DA, Glauser TA. Even a single seizure negatively impacts pediatric health-related quality of life. Epilepsia. 2009 Sep;50(9):2110-6.

Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics. 2008 Apr;121(4):e961-6.